BIO 2019 - Tagged with Interest Area>Intellectual Property

emergingopp_icon

Emerging Opportunities in Global Markets

India's Contribution in Global Biotech R&D

115B, Level 100

Prof. Stephen SammutSenior Fellow Health Care Management. Lecturer - Entrepreneurship atWharton School of Business Kate BealeAssociate Vice President for International Advocacy atPharmaceutical Research and Manufacturers of America, PhRMA Dr. Christiane HamacherCEO atBiocon Biologics India Limited Mr. Amit KapoorHonorary Chairman atInstitute for Competitiveness, India Dr. Cyrus KarkariaPresident atLupin Limited Dr. Alka SharmaScientist G atDepartment of Biotechnology, Government of India

intellectualproperty_icon

Intellectual Property

Patentable Subject Matter Around the World: Life Science Inventions in Canada, Europe, China, Australia and New Zealand

118C, Level 100

Dr. Eric WilliamsPartner atBarnes & Thornburg LLP Dr. Carmela De LucaPartner atBereskin & Parr LLP Mr. Alain DongManaging Partner atChina IPWell Law Firm Mr. David NowakDirector atHenry Hughes IP David SpinnerPartner atGreaves Brewster LLP

intellectualproperty_icon

Intellectual Property

The BPCIA is Turning Ten: What's Next for Biosimilars?

118C, Level 100

Steven MaslowskiPartner atAkin Gump Strauss Hauer & Feld LLP Paul GolianVice President & Assistant General Counsel atBristol-Myers Squibb Julia PikeVice President of Intellectual Property, North America atSandoz Chandrika ViraDirector atSterne, Kessler, Goldstein & Fox P.L.L.C.

emergingopp_icon

Emerging Opportunities in Global Markets

There is $200B in Global Investment in the Biopharmaceutical Sector Each Year. Who’s Getting It and Why?

115A, Level 100

Meir Pugatch Managing Director & Professor atPugatch Consilium; University of Maastricht Dr. Woei-Jer ChuangDirector General, Department of Life Sciences atMinistry of Science and Technology, Taiwan Ancizar Guerrero GilForeign Investment Executive Director in the United States atProcolombia Park Jee MinDeputy Director of the Division of Health Industry Promotion atMinistry of Health and Welfare (MoHW) Michael PergineAssociate Vice President, International Policy and Government Affairs atMerck & Co. Prof. Peter PittsPresident and Co-Founder atCenter for Medicine in the Public Interest

regulatoryinnovation

Regulatory Innovation

Transparency of clinical trial data – A hidden treasure, a ticking bomb or a regulatory reality

118C, Level 100

Ute KilgerPartner atBoehmert & Boehmert Sebastian EngelsAttorney at Law (Germany) atBoehmert & Boehmert Darshan Kulkarni, Pharm.D, MS, Edq.Principal Attorney atKulkarni Law Firm Liz RobertsSenior Director and Global Public Policy Lead atUCB